A research article by Dr Daniela Trabattoni et al, assessing bleeding control with QuikClot after vascular closure device use in patients undergoing transcatheter aortic valve implantation (TAVI). Large arterial sheath size use in TAVI patients may lead to vascular complications and bleeding. QuikClot® haemostatic products are different from standard surgical gauzes and other haemostatic agents. They stop bleeding significantly faster and are more effective than standard gauzes—and they are just as safe and intuitive to use. Unlike other haemostats, QuikClot® devices are impregnated with kaolin, an inorganic mineral that accelerates the body’s natural clotting ability and produces no exothermic reaction. You or your team can achieve haemostasis confidently—without worry of instigating an allergic response.
See full text of article here